HomeBusinessHealthcare Industry Stock NewsDisc Medicine (IRON) CEO On Hematologic Diseases

Disc Medicine (IRON) CEO On Hematologic Diseases

Disc Medicine (IRON) is a clinical-stage biopharmaceutical company. Disc Medicine (IRON) has built deep expertise in the role of iron homeostasis in hematologic disorders. The biotech company is expanding their portfolio with these highly complementary antibody programs. CEO John Quisel weighs in on agreeing to pay $10M to Mabwell Therapeutics as a down payment.

Market On Close

23 Jan 2023

SHARE

ON AIR
education
3:30 pm
Your First Trade
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
ON AIR
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now